Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Theravance Biopharma, Inc. | 10%+ Owner | COM | 9.51M | $74.2M | $7.80 | Aug 7, 2024 | Indirect |
Stagwell Inc | Director | Class A Common Stock | 7.15M | $50.2M | $7.02 | Oct 1, 2024 | Indirect |
SYNOVUS FINANCIAL CORP | 10%+ Owner | Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 1.29M | $32.6M | $25.20 | Jun 10, 2024 | Indirect |
PFSWEB INC | 10%+ Owner | Common Stock | 2.63M | $19.7M | $7.50 | Dec 29, 2022 | Indirect |
Stagwell Inc | Director | Class A Common Stock | 93.5K | $656K | $7.02 | Oct 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STGW | Stagwell Inc | Oct 1, 2024 | 1 | $20K | 4 | Oct 3, 2024 | Director |
tbph | Theravance Biopharma, Inc. | Aug 7, 2024 | 1 | $7.8M | 4 | Aug 9, 2024 | 10%+ Owner |
STGW | Stagwell Inc | Jul 1, 2024 | 1 | $20K | 4 | Jul 3, 2024 | Director |
STGW | Stagwell Inc | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
SNV PR E | SYNOVUS FINANCIAL CORP | Jun 10, 2024 | 1 | -$4.36M | 4 | Jun 11, 2024 | 10%+ Owner |
SNV PR E | SYNOVUS FINANCIAL CORP | Jun 5, 2024 | 3 | -$180K | 4 | Jun 7, 2024 | 10%+ Owner |
SNV PR E | SYNOVUS FINANCIAL CORP | May 31, 2024 | 3 | -$5.52M | 4 | Jun 4, 2024 | 10%+ Owner |
TBPH | Theravance Biopharma, Inc. | May 1, 2024 | 2 | $13.1M | 4 | May 3, 2024 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Oct 20, 2023 | 1 | $12K | 4 | Oct 24, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Oct 12, 2023 | 2 | $97.1K | 4 | Oct 16, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Oct 9, 2023 | 3 | $62.2K | 4 | Oct 11, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Oct 2, 2023 | 1 | $73.8K | 4 | Oct 4, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Sep 27, 2023 | 1 | $260K | 4 | Sep 28, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Sep 22, 2023 | 3 | $559K | 4 | Sep 26, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Sep 19, 2023 | 3 | $5.2M | 4 | Sep 21, 2023 | 10%+ Owner |
SNV | SYNOVUS FINANCIAL CORP | Aug 11, 2023 | 0 | $0 | 3 | Aug 18, 2023 | 10%+ Owner |
STGW | Stagwell Inc | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
STGW | Stagwell Inc | Mar 10, 2023 | 1 | $5.06M | 4 | Mar 14, 2023 | Director |
PFSW | PFSWEB INC | Dec 28, 2022 | 4 | $0 | 4 | Dec 30, 2022 | 10%+ Owner |
TBPH | Theravance Biopharma, Inc. | Sep 20, 2022 | 0 | $0 | 3 | Oct 21, 2022 | 10%+ Owner |
PFSW | PFSWEB INC | Jun 24, 2022 | 1 | $275K | 4 | Jun 28, 2022 | 10%+ Owner |
PFSW | PFSWEB INC | Jun 14, 2022 | 2 | $159K | 4 | Jun 17, 2022 | 10%+ Owner |
STGW | Stagwell Inc | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
STGW | Stagwell Inc | May 10, 2022 | 3 | $4.45M | 4 | May 12, 2022 | Director |
PFSW | PFSWEB INC | Apr 27, 2022 | 3 | $710K | 4 | Apr 29, 2022 | 10%+ Owner |
PFSW | PFSWEB INC | Apr 22, 2022 | 3 | $954K | 4 | Apr 26, 2022 | 10%+ Owner |
PFSW | PFSWEB INC | Feb 22, 2022 | 0 | $0 | 3 | Apr 21, 2022 | 10%+ Owner |
STGW | Stagwell Inc | Dec 3, 2021 | 2 | $2.38M | 4 | Dec 7, 2021 | Director |
STGW | Stagwell Inc | Nov 30, 2021 | 3 | $3.44M | 4 | Dec 2, 2021 | Director |
STGW | Stagwell Inc | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Director |
STGW | Stagwell Inc | Aug 3, 2021 | 0 | $0 | 3 | Aug 11, 2021 | Director |